<p>This is the first study examining the relationship between clonal hematopoiesis and clinical outcomes in prostate cancer patients. We used a targeted gene sequencing panel to identify patients in the A031201 clinical trial with and without clonal hematopoiesis. We found that clonal hematopoiesis did not affect overall or progression free survival in A031201 but was associated more adverse cardiac events.</p>

Molecular Analysis of Alliance A031201 Study

Prostatic Neoplasms study with Targeted-Capture data on dbGaP (957 participants)

Molecular Analysis of Alliance A031201 Study

Description

Applying For Access

Summary